DARSHNA SHAHIWALA: Open Payments
NPI 1982262614 · ALLEN, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,152 in 52 payments from 17 companies in 2025. Trend: 2023 $556 · 2024 $855 · 2025 $1,152
Food & beverage: $1,152
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 7 | $215 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $186 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 7 | $144 |
| Kowa Pharmaceuticals America, Inc. | 6 | $100 |
| VIVUS LLC | 5 | $85 |
| GlaxoSmithKline, LLC. | 3 | $69 |
| Novo Nordisk Inc | 3 | $64 |
| Dexcom, Inc. | 3 | $60 |
| Phathom Pharmaceuticals, Inc. | 3 | $48 |
| Aimmune Therapeutics, Inc. | 2 | $38 |
Products named: Kerendia, JARDIANCE, AIRSUPRA, ZORYVE, PANCREAZE, Dexcom G6 Transmitter, TRELEGY ELLIPTA, FARXIGA.
Industry payments across TX — which companies pay providers there.
